We aware that Erlotinib product patent is granted in India as 196774 (537/DEL/1996) and is is subject of many patent infringement cases filed at Delhi high court. Applicant has a divisional application (2018/CHE/2006) of ‘774 patent, which is pending at IPO Chennai.

A communication from Applicant’s attorney states that they wish to withdraw the 2018/CHE/2006 application.

This 2018 application was filed on 02/11/2006 and published on 26/03/2010. This application is subject of pre grant oppositions (filed by two Indian companies).

Note: iPAIRS status has not been changed yet.

About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s